Delgado also conducted stimoceiver experiments in cats, monkeys, chimpanzees, and even
human psychiatric patients.
The new study — published October 18, 2016 in the journal Molecular Psychiatry — combined genetic analysis of more than 9,000
human psychiatric patients with brain imaging, electrophysiology, and pharmacological experiments in mutant mice to suggest that mutations in the gene DIXDC1 may act as a general risk factor for psychiatric disease by interfering with the way the brain regulates connections between neurons.
Delgado implanted similar electrode arrays, or «stimoceivers,» in the brains of cats, monkeys, chimpanzees, and even
human psychiatric patients.
Not exact matches
By reprogramming
human skin cells and other cells from
patients with neurologic and
psychiatric diseases into induced pluripotent stem cells (iPSCs) and induced neurons (iN), his work seeks to decipher the progression and mechanisms that lead to brain cell dysfunction.